p53-MDM2 inhibitors (Cancer Research Technology)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namep53-MDM2 inhibitors (Cancer Research Technology)
Drug Alias NameMDM2-p53 inhibitors (Cancer Research Technology)NCL-00016149AW-393
ClassificationSmall molecules
Mechanisms of Actionp53-binding protein Mdm-2 inhibitors
Targetsp53-binding protein Mdm-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research Technology
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A